Bacteria shredding tech to fight drug-resistant superbugs

SKIP TO CONTENT
Search

Bacteria shredding tech to fight drug-resistant superbugs

Researchers have used liquid metals to develop new bacteria-destroying technology that could be the answer to the deadly problem of antibiotic resistance.

The technology uses nano-sized particles of magnetic liquid metal to shred bacteria and bacterial biofilm – the protective “house” that bacteria thrive in – without harming good cells.

Published in ACS Nano, the research led by RMIT offers a groundbreaking new direction in the search for better bacteria-fighting technologies.

Antibiotic resistance is a major global health threat, causing at least 700,000 deaths a year. Without action, the death toll could rise to 10 million people a year by 2050, overtaking cancer as a cause of death.

The biggest issues are the spread of dangerous, drug-resistant superbugs and the growth of bacterial biofilm infections, which can no longer be treated with existing antibiotics.

13 January 2020

Share

Golden Staph bacteria before (left) and after (right) exposure to the magnetic liquid metal nanoparticles. In the images, magnified 70,000 times, sharp pieces of liquid metal particle can be seen physically disrupting the bacteria after treatment. Golden Staph bacteria before (left) and after (right) exposure to the magnetic liquid metal nanoparticles. In the images, magnified 70,000 times, sharp pieces of liquid metal particle can be seen physically disrupting the bacteria after treatment.

Dr Aaron Elbourne said antibiotics had revolutionised health since they were discovered 90 years ago but were losing effectiveness due to misuse.

“We’re heading to a post-antibiotic future, where common bacterial infections, minor injuries and routine surgeries could once again become deadly,” Elbourne, a Postdoctoral Fellow in the Nanobiotechnology Laboratory at RMIT, said.

“It’s not enough to reduce antibiotic use, we need to completely rethink how we fight bacterial infections.

“Bacteria are incredibly adaptable and over time they develop defences to the chemicals used in antibiotics, but they have no way of dealing with a physical attack.

“Our method uses precision-engineered liquid metals to physically rip bacteria to shreds and smash through the biofilm where bacteria live and multiply.

“With further development, we hope this technology could be the way to help make antibiotic resistance history.” 

Let’s get physical: New way to kill bacteria

The RMIT team behind the technology is the only group in the world investigating the antibacterial potential of magnetic liquid metal nanoparticles.

When exposed to a low-intensity magnetic field, these nano-sized droplets change shape and develop sharp edges

When the droplets are placed in contact with a bacterial biofilm, their movements and nano-sharp edges break down the biofilm and physically rupture the bacterial cells.

In the new study, the team tested the effectiveness of the technology against two types of bacterial biofilms (Gram-positive and Gram-negative).

After 90 minutes of exposure to the liquid metal nanoparticles, both biofilms were destroyed and 99% of the bacteria were dead. Importantly, laboratory tests showed the bacteria-destroying droplets did not affect human cells.

13 January 2020

Share

Precision-engineered magnetic liquid metal nanoparticles, which change shape and develop sharp edges after exposure to a magnetic field (image magnified 1,000 times). Precision-engineered magnetic liquid metal nanoparticles, which change shape and develop sharp edges after exposure to a magnetic field (image magnified 1,000 times).

Postdoctoral Fellow Dr Vi Khanh Truong said the versatile technology could one day be used in a range of ways to treat infections.

“It could be used as a spray coating for implants, to make them powerfully antibacterial and reduce the high rates of infection for procedures like hip and knee replacements,” said Truong.

“There’s also potential to develop this into an injectable treatment that could be used at the site of infection.”

The next stage for the research - testing the effectiveness of the technology in pre-clinical animal trials - is already underway, with the team hoping to move to clinical human trials in coming years.

Led by Truong, Elbourne and Dr James Chapman, the multi-disciplinary team is also planning to expand the technology beyond antibacterial treatment, exploring how it could be used to:

  • treat fungal infections - the next superbugs
  • break through cholesterol plaques and battle heart problems
  • stop tumours by being injected directly into cancer cells.
PhD researcher Sheeana Gangadoo, Dr James Chapman, Dr Aaron Elbourne and Dr Vi Khanh Truong. PhD researcher Sheeana Gangadoo, Dr James Chapman, Dr Aaron Elbourne and Dr Vi Khanh Truong.

‘Antibacterial Liquid Metals: Biofilm Treatment via Magnetic Activation’, with collaborators from CSIRO, the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, UNSW and North Carolina State University, is published in ACS Nano (DOI: 10.1021/acsnano.9b07861).

Truong is currently at North Carolina State University on a Fulbright Scholarship, working with liquid metal science pioneer Professor Michael Dickey to further the research.

The research was supported by the CASS Foundation and the Australian-American Fulbright Commission.

Elbourne recently received an Early Career Medical Researchers Grant from the Jack Brockhoff Foundation for his work on the project, which has also been supported by donations from RMIT alumni. 

Find out how to donate and support further development of this groundbreaking technology. 

 

The complex challenges we face as a society call for shared solutions. Join local and international leaders across industry, research and innovation, as we identify collaborative opportunities to shape our future. Find out more at Engaging for Impact 2020 (4-6 February).

 

Story: Gosia Kaszubska

  • Research
  • Nano & Microtechnology
  • Science and technology
Engage

Related News

How does our brain fold? Study reveals new genetic insights

New research is helping unlock the mystery of how the brain folds as a baby develops in the womb – a process critical to healthy brain function.

Muscle tech: Sleep apnea therapeutic showcased at global biotech event

A world-first therapeutic for treating sleep apnea and a range of other weak muscle conditions will be unveiled this month at global biotech innovation event, BIO Digital.

Emerging technology for the future of health and social care

From biomedicine and 3D printed implants to data collection and virtual care, RMIT experts discuss how emerging technologies are shaping the sector and helping solve our most complex health challenges.

New thinking: changing tack in the fight against viral infections

As the coronavirus pandemic highlights our deep vulnerability to novel viruses, researchers are bringing new ways of thinking to the development of desperately needed anti-viral treatments.

Show more
Subscribe to RMIT NewsSubscribe
aboriginal flag
torres strait flag

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business.

More information